Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-30 @ 2:47 AM
Study NCT ID:
NCT05218603
Status:
UNKNOWN
Last Update Posted:
2022-09-16
First Post:
2022-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT
Sponsor:
PETHEMA Foundation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11-06
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-17
First Submit QC Date:
None
Study First Post Date:
2022-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-15
Last Update Post Date:
2022-09-16
Last Update Post Date Type:
ACTUAL